Evidence map›Paper›PMID 41175258›Full record

ArticleWorld journal of microbiology & biotechnology2025

Unraveling lignocellulosic xylan degradation by a novel strain of Streptomyces sp.: an exploration through genomic and transcriptomic perspectives.

Leya Thomas, Ravisankar Valsalan, Deepu Mathew

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leya ThomasCentre for Plant Biotechnology and Molecular Biology, Kerala Agricultural University, Thrissur, 680656, India.
Ravisankar ValsalanCentre for Plant Biotechnology and Molecular Biology, Kerala Agricultural University, Thrissur, 680656, India.
Deepu MathewCentre for Plant Biotechnology and Molecular Biology, Kerala Agricultural University, Thrissur, 680656, India. deepu.mathew@kau.in.ORCID http://orcid.org/0000-0002-2941-1060

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A strain of Streptomyces sp., KAU_LT, possessing industrial significance and exhibiting xylanase activity at a level of 5088.92 ± 167.22 IU/gds, was isolated and characterized. The xylanase enzyme exhibited remarkable tolerance and stability across a wide pH range (6.0-10.0) and temperatures up to 70 °C. Media optimization resulted in 20-fold increased enzyme production during Solid-State Fermentation, bypassing the necessity for agro-residue pre-treatment. The whole genome sequencing through Illumina-Nanopore hybrid strategy followed by annotation has revealed its extensive carbohydrate-active enzyme repertoire. The 16S rRNA phylogenetic analysis has identified the strain as a relative of the novel Streptomyces nigra. The transcriptome sequencing and analysis identified endo-1,4-β-xylanase (xlnB) as one of the top upregulated genes. Among the xylanolytic genes predicted from the whole genome annotation, xlnB was 660-fold upregulated, contributing to most of the xylan degradation during Solid-State Fermentation process. The strain's capability to produce xylo-oligosaccharides highlights its applications across diverse industries.

Indexed as

LigninStreptomycesXylansBacterial ProteinsEndo-1,4-beta XylanasesEnzyme StabilityFermentationGene Expression ProfilingGenome, BacterialGenomicsHydrogen-Ion ConcentrationPhylogenyRNA, Ribosomal, 16STemperatureTranscriptomeWhole Genome SequencingBacterial ProteinsEndo-1,4-beta XylanasesLigninlignocelluloseRNA, Ribosomal, 16SXylansCarbohydrate active enzymesGenome sequenceResponse surface methodologyRT-qPCRSolid-State Fermentation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.